However, it is noteworthy that ten oligonucleotide drugs have been officially approved by FDA as of January 2020 [55], which means that the technological obstacles for oligonucleotide therapeutics are being solved step by step and the development of oligonucleotide drugs targeting NNMT is still a promising method for the prevention or treatment of obesity and related T2D in the future
Alexander Shapsis , Board-Certified Gastroenterologist 16+ years of experience in weight-loss and metabolic medicine 2,000+ happy patients with real, lasting transformations Doctor-supervised GLP-1 programs for safe and effective results Serving Brooklyn, NY and the Tristate area (NY, NJ, CT) Address: 2797 Ocean Pkwy, Suite 1, Brooklyn, NY 11235 Phone: (877) 749-3633 877-Size-Off Drop Weight
The lower limit of quantification for the analytical assay was 50 ng ml 1
That said, BPC-157 is still considered an investigational compound and not approved by the FDA
Eligible for 1.5 hours of #CPEcredit